F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
New York Times · LC · trust 36/100
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
Read the original at New York Times →
Open in TruthVane →